Chinese fine chemicals manufacturer Huadao Biopharma announced last week the completion of a series B round of financing worth RMB100 million (US$14.18 million) led by Shenzhen-listed chemicals developer NKY Medical Holdings.
Chinese Fine Chemicals Manufacturer Huadao Biopharma Closes $14M Series B Round comes originally from China Money Network<... This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of